Literature DB >> 27878387

Genetic susceptibility to cutaneous radiation injury.

Amy Huang1, Sharon A Glick2.   

Abstract

The use of ionizing radiation is critical to cancer treatment and fluoroscopic procedures. However, despite efforts to minimize total radiation dose, many patients experience toxic cutaneous side-effects of ionizing radiation, ranging from mild erythema to subcutaneous fibrosis, telangiectasia formation, and ulceration. Extent of injury is highly variable among patients. Studying the genetic determinants of radiation injury can help develop protocols to reduce radiation toxicity, as well as drive research into effective modulators of the genes and gene products associated with radiation injury. Many studies in the past two decades have identified single-nucleotide polymorphisms that may be associated with susceptibility to cutaneous radiation injury, such as those in genes related to the following cellular responses to ionizing radiation: inflammation, DNA repair, oxidation and stress response, and cell-cycle and apoptosis. This review summarizes the current literature on potential major genes and polymorphisms, in the previously described damage response pathways, that are involved in susceptibility to cutaneous radiation injury. Potential pitfalls of current research and further avenues of discovery will be explored.

Entities:  

Keywords:  Genome-wide association study; Oncodermatology; Radiation dermatitis; Radiation therapy; Radiogenomics; Single nucleotide polymorphisms

Mesh:

Substances:

Year:  2016        PMID: 27878387     DOI: 10.1007/s00403-016-1702-3

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  2 in total

1.  Proton beam therapy with concurrent chemotherapy is feasible in children with newly diagnosed rhabdomyosarcoma.

Authors:  Ryoko Suzuki; Hiroko Fukushima; Hajime Okuwaki; Masako Inaba; Sho Hosaka; Yuni Yamaki; Takashi Fukushima; Kouji Masumoto; Masashi Mizumoto; Hideyuki Sakurai; Hidetoshi Takada
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12

2.  The relationship between TNF-α gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer.

Authors:  Radosław Mlak; Tomasz Powrózek; Anna Brzozowska; Iwona Homa-Mlak; Marcin Mazurek; Paweł Gołębiowski; Grzegorz Sobieszek; Teresa Małecka-Massalska
Journal:  Support Care Cancer       Date:  2019-05-10       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.